We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+5.07%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
10 Year Est. Return
AUM
$15.8B
AUM Growth
+$2.12B
Cap. Flow
+$1.31B
Cap. Flow %
8.29%
Top 10 Hldgs %
13.54%
Holding
1,739
New
469
Increased
384
Reduced
350
Closed
529

Sector Composition

Rank Sector Weight
1 Healthcare 19.65%
2 Technology 16.89%
3 Consumer Discretionary 13.55%
4 Industrials 12.67%
5 Financials 6.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CIT
876
DELISTED
CIT Group Inc.
CIT
$1.39M 0.01%
+28,313
New +$1.33M
OSK icon
877
Oshkosh
OSK
$9.59B
$1.38M 0.01%
+16,663
New +$1.22M
DFIN icon
878
Donnelley Financial Solutions
DFIN
$1.16B
$1.38M 0.01%
62,667
-103,475
-62% -$2.24M
EQNR icon
879
Equinor
EQNR
$92.4B
$1.38M 0.01%
+68,887
New +$1.27M
RYAAY icon
880
Ryanair
RYAAY
$31.3B
$1.37M 0.01%
+32,568
New +$1.47M
KA
881
DELISTED
Kineta, Inc. Common Stock
KA
$1.37M 0.01%
4,887
JRVR icon
882
James River Group Holdings
JRVR
$217M
$1.37M 0.01%
33,335
-194,736
-85% -$7.77M
CASS icon
883
Cass Information Systems
CASS
$743M
$1.36M 0.01%
+28,561
New +$1.36M
PSTB
884
DELISTED
Park Sterling Corp.
PSTB
$1.36M 0.01%
113,475
+45,239
+66% +$525K
SYBT icon
885
Stock Yards Bancorp
SYBT
$2.6B
$1.36M 0.01%
+35,809
New +$1.29M
MIDD icon
886
Middleby
MIDD
$6.08B
$1.35M 0.01%
10,589
-54,605
-84% -$6.73M
IDCC icon
887
InterDigital
IDCC
$8.89B
$1.35M 0.01%
18,269
-27,130
-60% -$1.99M
ITCI
888
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$1.35M 0.01%
+84,358
New +$1.24M
WVE icon
889
Wave Life Sciences
WVE
$1.2B
$1.35M 0.01%
61,286
HEI.A icon
890
HEICO Corp Class A
HEI.A
$37.2B
$1.33M 0.01%
+34,203
New +$1.25M
BBWI icon
891
Bath & Body Works
BBWI
$4.1B
$1.33M 0.01%
+39,160
New +$1.31M
HIBB
892
DELISTED
Hibbett, Inc. Common Stock
HIBB
$1.33M 0.01%
94,697
+33,297
+54% +$494K
ISCA
893
DELISTED
International Speedway Corp
ISCA
$1.29M 0.01%
+35,815
New +$1.25M
CVSA
894
Covista Inc
CVSA
$4.8B
$1.28M 0.01%
+35,500
New +$1.21M
HT
895
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
$1.28M 0.01%
67,135
+27,639
+70% +$508K
SSNC icon
896
SS&C Technologies
SSNC
$18.6B
$1.27M 0.01%
+31,854
New +$1.23M
HOG icon
897
Harley-Davidson
HOG
$2.71B
$1.27M 0.01%
+26,535
New +$1.29M
IPCC
898
DELISTED
Infinity Property & Casualty C
IPCC
$1.27M 0.01%
13,544
+1,721
+15% +$160K
NPTN
899
DELISTED
NEOPHOTONICS CORP
NPTN
$1.27M 0.01%
211,287
-402,206
-66% -$2.71M
CI icon
900
Cigna
CI
$74.6B
$1.26M 0.01%
6,729
-136,513
-95% -$24.3M

Similar funds

Marshall Wace North America's Q3 2017 Portfolio in Review

As of Q3 2017, Marshall Wace North America held 1,739 positions worth $15.8B, up 16% from $13.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Marshall Wace North America deployed $1.31B of net new capital in Q3 2017, opening 469 new positions and adding to 384 existing holdings. Its largest new stake was Delta Air Lines: 1,523,510 shares worth $73.1M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Terminix Global Holdings, Inc., an estimated $113M trimmed.

  • Marshall Wace North America's largest Q3 2017 buy was Delta Air Lines: 1,523,510 shares worth $73.1M.
  • Marshall Wace North America added most to Johnson & Johnson in Q3 2017, an estimated $260M increase.
  • Marshall Wace North America's biggest Q3 2017 reduction was Terminix Global Holdings, Inc., cutting an estimated $113M.
  • Marshall Wace North America fully exited Reynolds American Inc in Q3 2017, selling an estimated $130M.
  • Marshall Wace North America's ten largest holdings make up 14% of its $15.8B portfolio in Q3 2017.
  • Marshall Wace North America opened 469 new positions and closed 529 in Q3 2017.
  • Marshall Wace North America's portfolio value rose 16% quarter-over-quarter to $15.8B.

Based on Marshall Wace North America's 13F filing for Q3 2017, filed 13 Nov 2017.